GlassScriptPhysician profile
Thomas M Mcgowan
NPI 1033173893
$20,761.74
in general payments reported to CMS, 2019-2025
66 companies · $4,144 in 2025
The $4,144 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,331 · 2020: $2,344 · 2021: $2,824 · 2022: $2,502 · 2023: $2,834 · 2024: $3,783 · 2025: $4,144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,759.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,884.90 | 2019-2025 | |
| Novo Nordisk INC | $2,516.95 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $2,209.77 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $1,408.91 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $1,248.27 | 2019-2025 | Repatha, Otezla, Otezla |
| Merck Sharp & Dohme LLC | $903.63 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $764.45 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Takeda Pharmaceuticals U.S.A., INC. | $692.23 | 2019-2025 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $562.87 | 2023-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $485.17 | 2019-2025 | Xifaxan |
| Allergan, INC. | $484.33 | 2019-2020 | |
| Axsome Therapeutics, INC. | $445.16 | 2023-2025 | Auvelity |
| Horizon Therapeutics Plc | $443.49 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $391.69 | 2022-2025 | |
| Corium, LLC | $373.89 | 2022-2024 | Azstarys |
Show all 66 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $365.45 | 2022-2025 | Rexulti |
| Glaxosmithkline, LLC. | $333.60 | 2019-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Supernus Pharmaceuticals, INC. | $268.97 | 2021-2025 | Qelbree, Qelbree |
| Exact Sciences Corporation | $267.71 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Janssen Pharmaceuticals, INC | $236.39 | 2019-2025 | Spravato |
| Biohaven Pharmaceutical Holding Company LTD. | $234.01 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $226.55 | 2020-2021 | |
| Currax Pharmaceuticals LLC | $215.40 | 2020-2023 | Contrave |
| Sanofi-Aventis U.S. LLC | $193.95 | 2019-2022 | |
| Ibsa Pharma INC. | $158.37 | 2019-2025 | Tirosint, Flector, Licart |
| Amarin Pharma, INC. | $153.78 | 2020-2021 | |
| Abbott Laboratories | $152.28 | 2021-2025 | Freestyle Libre 3 |
| Ironshore Pharmaceuticals INC. | $150.70 | 2021-2024 | Jornay Pm |
| Kowa Pharmaceuticals America, INC. | $132.60 | 2019-2023 | Seglentis |
| Vanda Pharmaceuticals INC. | $121.22 | 2025 | Fanapt |
| Idorsia Pharmaceuticals US INC | $120.85 | 2023-2025 | Quviviq, Quviviq |
| Vivus LLC | $114.44 | 2020-2025 | Qsymia, Pancreaze |
| Corcept Therapeutics | $112.51 | 2025 | Korlym |
| Tris Pharma INC | $107.90 | 2022-2024 | Dyanavel Xr |
| Sanofi Pasteur INC. | $87.81 | 2019-2023 | |
| Ironwood Pharmaceuticals, INC | $75.75 | 2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $71.48 | 2025 | Caplyta |
| Lucid Diagnostics INC. | $66.95 | 2025 | |
| Philips North America LLC | $62.14 | 2025 | Vest Therapy Und, Disposable Vest |
| Antares Pharma, INC. | $60.53 | 2019 | |
| Genentech USA, INC. | $60.09 | 2019-2023 | Columvi, Polivy |
| Teva Pharmaceuticals USA, INC. | $59.53 | 2020-2021 | |
| Verity Pharmaceuticals INC. | $56.77 | 2024-2025 | Tlando |
| Inspire Medical Systems, INC. | $54.04 | 2024 | Inspire |
| Shire North American Group INC | $51.32 | 2019 | |
| Esperion Therapeutics, INC. | $50.46 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $47.51 | 2019 | |
| Jazz Pharmaceuticals INC. | $47.00 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $43.30 | 2025 | Neffy |
| Impel Pharmaceuticals INC. | $43.18 | 2023 | Trudhesa |
| Scilex Pharmaceuticals INC. | $36.33 | 2019 | |
| Pfizer INC. | $33.68 | 2019-2022 | |
| Daiichi Sankyo INC. | $31.23 | 2020 | |
| Phadia US INC. | $30.92 | 2025 | Immunocap |
| Nalpropion Pharmaceuticals LLC | $27.71 | 2019 | |
| Mannkind Corporation | $21.51 | 2019 | |
| Viatris Specialty LLC | $20.13 | 2025 | Yupelri |
| Dexcom, INC. | $18.93 | 2025 | Dexcom G6 Transmitter |
| Cranial Technologies, INC | $17.74 | 2025 | Doc Band |
| Collegium Pharmaceutical, INC. | $16.72 | 2025 | Jornay Pm |
| Medicure Pharma INC. | $15.14 | 2023 | Zypitamag |
| Ardelyx, INC. | $15.06 | 2025 | Ibsrela |
| Adlon Therapeutics L.P. | $14.39 | 2020 | |
| Aytu Biopharma, INC. | $14.22 | 2019 | |
| Avanir Pharmaceuticals, INC. | $14.06 | 2021 | |
| Tolmar, INC. | $13.72 | 2025 | Jatenzo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mcgowan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.